ACHC Acadia Healthcare Company Inc.

Acadia Healthcare Forms Joint Venture With Tufts Medicine to Build a Behavioral Health Hospital to Serve the Boston Regional Area

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Tufts Medicine, one of Massachusetts’ elite health systems. The partnership anticipates building a new 144-bed behavioral health hospital at the site of the former Malden Hospital in Malden, Massachusetts, expanding access to critically needed inpatient behavioral health services.

For decades, the hospitals of Tufts Medicine – MelroseWakefield Hospital and Lawrence Memorial Hospital – have been known and highly respected for the inpatient behavioral healthcare that they provide the communities they serve. The proposed new hospital will offer the latest in inpatient behavioral healthcare and intensive outpatient programs, providing the continuum of care needed to support patients and their families. The new hospital will also serve as a teaching hospital, training students and residents from the Tufts University School of Medicine.

The hospital will care for patients of all ages, including the most vulnerable members of the community, especially its adolescent and elderly neighbors. Together, Acadia and Tufts Medicine will invest more than $65 million in expanding behavioral health resources in Boston. The new hospital represents the 17th joint venture partnership for Acadia.

“This facility will have a tremendous impact, bringing critically needed behavioral healthcare services to the area,” said Chris Hunter, Chief Executive Officer of Acadia Healthcare. “As we have proven in operating our joint ventures, we will bring the best practices of both organizations and expand access to quality behavioral healthcare services providing healing and hope to those in need in the surrounding communities. We will continue to partner with leading health systems to combat the mental healthcare and substance use crises across our country.”

“MelroseWakefield Hospital and Lawrence Memorial Hospital have served the behavioral health needs of our communities admirably, and we are proud to expand upon the legacy of high-quality, compassionate care through this joint venture with Acadia,” said Michael Dandorph, President and Chief Executive Officer of Tufts Medicine. “This facility will offer the critical inpatient behavioral health services that our community members need, while serving as a strong partner to residents, patients, their families, and medical providers across the region.”

About Acadia Healthcare

Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2022, Acadia operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds in 40 states and Puerto Rico. With more than 22,500 employees serving approximately 70,000 patients daily, Acadia is the largest stand-alone behavioral health company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

About Tufts Medicine

Tufts Medicine is a leading integrated health system bringing together the best of academic and community healthcare to deliver exceptional, connected and accessible care experiences to consumers across Massachusetts. Comprised of Tufts Medical Center, Lowell General Hospital, MelroseWakefield Hospital, Lawrence Memorial Hospital of Medford, an expansive home care network and a large integrated physician network. Tufts Medicine has more than 15,000 dedicated care team members providing more than 1.5 million patient experiences per year. The health system is the principal teaching affiliate for Tufts University School of Medicine. Tufts Medicine came together in 2014 to leverage the experience of its member organizations and integrate their missions to together transform the ways that consumers engage with and experience their care.

EN
30/06/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Acadia Healthcare Company Inc.

 PRESS RELEASE

Acadia Healthcare Announces Pricing of $550 Million Senior Notes Due 2...

FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today the pricing of its private offering (the “Offering”) of $550 million in aggregate principal amount of 7.375% senior notes due 2033 (the “Notes”), which represents an increase of $50 million in aggregate principal amount from its previous announcement. The Offering is expected to close on March 10, 2025. The closing of the Offering is subject to the satisfaction of customary closing and market conditions. The Company intends to use the proceeds from the Offering to prep...

Moody's Ratings assigns a Ba3 to Acadia's new senior unsecured notes

Moody's Ratings (Moody's) assigned a Ba3 rating to Acadia Healthcare Company, Inc.'s ("Acadia") proposed $500 million senior unsecured notes. There are no changes to the company's existing Ba2 Corporate Family Rating (CFR), Ba2-PD Probability of Default Rating, and Ba3 senior unsecured ratings. The ...

 PRESS RELEASE

Acadia Healthcare Announces Launch of $500 Million Senior Notes Offeri...

FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of $500 million in aggregate principal amount of senior notes due 2033 (the “Notes”), subject to market conditions and other considerations. The Company intends to use the proceeds from the Offering to prepay a portion of the outstanding borrowings under its existing senior secured revolving line of credit. The Notes have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), an...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Acadia Healthcare Company, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 26 February 2025 in which we reassessed the appropriateness of the ratings ...

 PRESS RELEASE

Acadia Healthcare Reports Fourth Quarter 2024 Results

FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenue totaled $774.2 million, an increase of 4.2% over the fourth quarter of 2023. Same facility revenue increased 4.7% compared with the fourth quarter of 2023, including an increase in patient days of 3.2% and an increase in revenue per patient day of 1.4%. Net income attributable to Acadia totaled $32.6 million, or $0.35 per diluted share. Adjuste...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch